Welcome to the MyBimzelx (bimekizumab)▼ patient website.

This website is intended only for people who live in the UK and Ireland that have been prescribed this treatment. ​

The website offers a range of resources designed to support patients and includes injection instructions, frequently asked questions and other useful information.

The information on this website is not intended as a substitute for consultation with your healthcare professional.

To enter the website, please complete the login form on the right.

I am a patient

To access this site, please enter either the code on your medicine box or the the code found within the brochure or leaflet that was provided by your healthcare professional or homecare delivery company.

What kind of code do you have?

Medicine box

Medicine Box

Medication brochure


How to find my code?

I am a Healthcare Professional

I am looking for more information about this treatment. Go to healthcare professional site.

I am not a patient using Bimzelx

I have not been prescribed this treatment, but would like to learn more about Psoriatic Arthritis. Go to UCBCares.

For more information about UCB Pharma, visit:

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. By reporting side effects you can help provide more information on the safety of this medicine.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient information leaflet. You can also report side effects directly in the UK via the Yellow Card Scheme website: or via the the MHRA Yellow Card App in the Google Play or Apple App Store. In Ireland please report via the HPRA at

You can also report adverse events to UCB at or

Bimzelx® is a registered trademark of the UCB Group of Companies.

IE-N-BK-PsA-2300007. Date of Preparation: July 2023

Images used are for illustrative purposes and are not of real patients